机译:Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status
Kobe City Med Ctr Gen Hosp, Dept Hematol, Kobe, Hyogo, Japan;
Shimane Univ, Ctr Community Based Healthcare Res & Educ, Matsue, Shimane, Japan;
Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, JapanAichi Med Univ, Div Hematol, Dept Internal Med, Nagakute, Aichi, JapanToranomon Gen Hosp, Dept Hematol, Tokyo, JapanKomagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, JapanNatl Hosp Org Kumamoto Med Ctr, Dept Hematol, Kumamoto, JapanNatl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, JapanSaitama Med Ctr Jichi Med Univ, Div Hematol, Saitama, JapanSapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, JapanJapanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, JapanHamanomachi Hosp, Dept Hematol, Fukuoka, JapanUniv Tsukuba Hosp, Dept Hematol, Tsukuba, Ibaraki, JapanKanagawa Canc Ctr, Dept Hematol, Yokohama, Kanagawa, JapanImamura Gen Hosp, Dept Hematol, Kagoshima, JapanJapanese Red Cross Kinki Block Blood Ctr, Preparat Dept, Osaka, JapanHiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, JapanJapanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, JapanAichi Canc Ctr, Dept Hematol & Cell Therapy, Nagoya, Aichi, Japan;